Evidence map›Paper›PMID 38722160›Full record

ReviewCardiology in review

Clinical Features of Cardiac Calcified Amorphous Tumor: A Narrative Review.

Yu Takahashi, Yusuke Inaba, Hiroshi Tsuchiya, Sachito Minegishi, Tetsuya Niino, Hidehito Endo, Hiroshi Kubota

Abstract readReview
In one paragraph

Review in Cardiology in review. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yu TakahashiFrom the Department of Cardiovascular Surgery, Kyorin University, Mitaka-shi, Japan.
Yusuke InabaFrom the Department of Cardiovascular Surgery, Kyorin University, Mitaka-shi, Japan.
Hiroshi TsuchiyaFrom the Department of Cardiovascular Surgery, Kyorin University, Mitaka-shi, Japan.
Sachito MinegishiFrom the Department of Cardiovascular Surgery, Kyorin University, Mitaka-shi, Japan.
Tetsuya NiinoDepartment of Cardiovascular Surgery, National Hospital Organization Disaster Medical Center, Tachikawa-shi, Japan.
Hidehito EndoFrom the Department of Cardiovascular Surgery, Kyorin University, Mitaka-shi, Japan.
Hiroshi KubotaFrom the Department of Cardiovascular Surgery, Kyorin University, Mitaka-shi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A cardiac calcified amorphous tumor (CAT) is a non-neoplastic cardiac mass composed of calcified nodules surrounded by amorphous fibrous tissue in a context of degeneration and chronic inflammation. Although CAT cases are increasingly reported, its clinical manifestation remains unclear. We aimed to conduct a narrative review of CAT and identify its clinical characteristics. We conducted a comprehensive literature search using PubMed, with the keyword "Cardiac Calcified Amorphous Tumor" to identify relevant articles. A total of 113 articles published between 1997 and 2022 were retrieved. The clinical features allowing for assess patient background, differences with and without end-stage renal disease (ESRD), symptom-related factors, risk factors for embolism caused by CAT, and features of CAT, such as shape, location, mobility, pathology, and treatment, were statistically analyzed in 106 criteria-matched cases. The mean patient age was 60.2 ± 18.6 years, with 45 men and 61 women. Of the data collected from 21 countries, 52 patients were from Japan. Mobile CAT was more common in the chronic renal failure group. Linear, club-shaped, and spindle-shaped CAT tended to be mobile and more common in the ESRD group as well as located in the mitral valve region. The shape, mobility, location, and underlying mechanism of CAT depended on the presence or absence of ESRD. The risk of embolism was considered high because mobile CAT was more common in the ESRD group, and CAT originated in the mitral valve region. Hence, early diagnosis based on periodic examination in patients with ESRD and aggressive surgical treatment are necessary.

Indexed as

CalcinosisCardiomyopathiesHeart NeoplasmsHumansKidney Failure, ChronicRisk Factorscardiac calcified amorphous tumorend-stage renal diseasehemodialysis

Identifiers

PMID38722160
PMCPMC13440605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.